At the half-year point 2018 is shaping up to have the lowest spend on medical device M&A since 2013. With only two billion-dollar deals closed in the past six months the total disclosed spend is less than $12bn, compared with $48.8bn a year ago – though admittedly that figure was swollen by the closure of Abbott’s purchase of St. Jude Medical.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,